Company Analysis

IRIDEX Corporation (IRIX)

Nasdaq: IRIX · Electromedical & Electrotherapeutic Apparatus · Mountain View, CA · filing with the SEC since 1996
Grade4.2
◀ Past 3.7● Present 4.7▶ Future 4.1
1 est.

Filings

254 filings since 2017 beside 285 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Oct 31, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Dec 15, 2026
10-K Annual report for the fiscal year ending Jan 3, 2027Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Apr 3, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 45 days after the quarter ended. The proxy statement was last filed Apr 24, 2026.

Filings a yearinsider forms included
64465539283311056
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 3 times in the last 36 months, the newest Sep 2, 2026.Officer or director change (8-K item 5.02): 10 times in the last 36 months, the newest Jun 13, 2025.SEC letters: 2 in the last 36 months, the newest Sep 20, 2024.A late-filing notice, Form NT 10-Q, filed Nov 14, 2023.
Insider forms 285

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Sep 2, 2026 8-K items 3.01, 9.01 Listing warning from its exchange · Current report Aug 27, 2026
Aug 18, 2026 10-Q Quarterly report Jul 4, 2026
Aug 18, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 16, 2026 8-K items 5.07, 7.01, 9.01 Shareholder vote; Investor disclosure (Regulation FD) · Current report Jul 10, 2026
Jul 13, 2026 SCHEDULE 13D/A Activist holder update, amended
Jun 18, 2026 8-K item 8.01 Other event · Current report Jun 12, 2026
Jun 1, 2026 SD Conflict minerals report
May 19, 2026 10-Q Quarterly report Apr 4, 2026
May 19, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 24, 2026 ARS Annual report to shareholders Jan 3, 2026
Apr 24, 2026 DEFA14A Extra proxy material
Apr 24, 2026 DEF 14A Proxy statement Jun 12, 2026
Apr 3, 2026 D/A Private placement notice, amended
Apr 2, 2026 10-K Annual report Jan 3, 2026
Mar 26, 2026 8-K items 2.02, 9.01 Results released · Current report
Mar 13, 2026 8-K items 1.01, 2.03, 9.01 Major agreement signed; New debt or obligation taken on · Current report Mar 9, 2026
Jan 12, 2026 8-K items 2.02, 9.01 Results released · Current report
Jan 8, 2026 SCHEDULE 13D Activist holder notice
Dec 11, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Nov 12, 2025 10-Q Quarterly report Sep 27, 2025
Nov 12, 2025 8-K items 2.02, 9.01 Results released · Current report Nov 11, 2025
Sep 9, 2025 8-K items 8.01, 9.01 Other event · Current report Aug 27, 2025
Aug 12, 2025 10-Q Quarterly report Jun 28, 2025
Aug 12, 2025 8-K items 2.02, 9.01 Results released · Current report
Jun 13, 2025 S-8 Employee stock plan registration
Jun 13, 2025 8-K items 5.02, 5.03, 5.07, 9.01 Officer or director change; Charter, bylaw or fiscal-year change; Shareholder vote · Current report Jun 11, 2025
Jun 2, 2025 DEFA14A Extra proxy material
May 30, 2025 SD Conflict minerals report
May 22, 2025 8-K items 1.01, 9.01 Major agreement signed · Current report May 20, 2025
May 20, 2025 DEFA14A Extra proxy material
May 20, 2025 8-K items 3.01, 9.01 Listing warning from its exchange · Current report May 14, 2025
May 20, 2025 DEFA14A Extra proxy material
May 13, 2025 10-Q Quarterly report Mar 29, 2025
May 13, 2025 8-K items 2.02, 9.01 Results released · Current report
Apr 28, 2025 ARS Annual report to shareholders Dec 28, 2024
Apr 28, 2025 DEFA14A Extra proxy material
Apr 28, 2025 DEF 14A Proxy statement Jun 11, 2025
Apr 17, 2025 PRE 14A Preliminary proxy statement
Apr 14, 2025 8-K items 2.02, 9.01 Results released · Current report
Apr 8, 2025 8-K items 5.02, 9.01 Officer or director change · Current report Apr 7, 2025
40 of 254 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton IRIX · research, not advice